Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Sodium Glucose Co-transporter 2-Inhibitors on Clinical Outcome and Left Ventricular Function in Patients Presented by Acute Myocardial Infarction

NCT06964607 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT06964607
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06964607 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Sodium Glucose Co-transporter 2-Inhibitors on Clinical Outcome and Left Ventricular Function in Patients Presented by Acute Myocardial Infarction
Lead sponsor
Tanta University
Phase
Observational
Overall status
Completed
Start date
April 1, 2023
Completion date
April 1, 2024
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocardial infarction, clinical outcome, inhibitors, left ventricule, sodium-glucose cotransporter 2